CUREPHARMA Trademark

Trademark Overview

On Thursday, July 23, 2020, a trademark application was filed for CUREPHARMA with the United States Patent and Trademark Office. The USPTO has given the CUREPHARMA trademark a serial number of 79300671. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, October 3, 2023. This trademark is owned by CUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.. The CUREPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical substances and preparations for the treatment of neurodegenerative conditions, diseases, and disorders
curepharma

General Information

Serial Number79300671
Word MarkCUREPHARMA
Filing DateThursday, July 23, 2020
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, October 3, 2023
Registration Number6648799
Registration DateTuesday, February 22, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements

Description of MarkThe mark consists of the term "CUREPHARMA" above a horizontal DNA helix.
Goods and ServicesPharmaceutical substances and preparations for the treatment of neurodegenerative conditions, diseases, and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, October 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN
Party NameCUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN
Party NameCUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events

Event DateEvent Description
Sunday, October 22, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, October 22, 2023DEATH OF INTERNATIONAL REGISTRATION
Monday, August 22, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 27, 2022GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, July 27, 2022GENERIC MADRID TRANSACTION CREATED
Sunday, May 22, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 22, 2022REGISTERED-PRINCIPAL REGISTER
Monday, December 13, 2021NOTIFICATION PROCESSED BY IB
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 17, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 6, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, June 22, 2021ATTORNEY REVIEW COMPLETED
Tuesday, May 18, 2021CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Sunday, May 16, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Monday, May 3, 2021REFUSAL PROCESSED BY IB
Saturday, April 10, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, April 10, 2021REFUSAL PROCESSED BY MPU
Wednesday, April 7, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 6, 2021NON-FINAL ACTION WRITTEN
Tuesday, March 30, 2021ASSIGNED TO EXAMINER
Friday, January 1, 2021APPLICATION FILING RECEIPT MAILED
Monday, December 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

curepharma conditions diseases disorders neurodegenerative treatment substances preparations pharmaceutical